EUVIMEDEUVIMED entdecken
Open Access

Quantifying emergent drug-resistant TB using laboratory data and record-linkage methods

C H Rhea, F Maruri, Y Ghebrekristos, G Amorim, H Cox, K Dheda, T R Sterling, R Warren, Y F van der Heijden

IJTLD Open · 2026-07 · 3 (7) · 428-434

DOI: 10.5588/ijtldopen.26.0043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IJTLD Open, online erschienen am 01.07.2026. Verfasst von C H Rhea und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology, Vanderbilt University School of Medicine, Nashville, TN, USA. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Clinicians, public health workers, and researchers must link multiple laboratory results to individual patient records to identify emerging drug-resistant TB. OBJECTIVE Determine the proportion of individuals with rifampicin-resistant TB (RR-TB) who developed fluoroquinolone resistance using different data matching methods. DESIGN Data from the National Health Laboratory Service (NHLS) from the Western Cape Province, South Africa (January 2008 to June 2015), were used to identify patients with RR-TB who developed fluoroquinolone resistance after initial susceptibility. We used four methods to link patient results: A) exact match on NHLS patient number; B) exact match on surname, first name, and date of birth; C) custom algorithm (Stellenbosch University) using approximate matches for patient-identifying variables; and D) custom iterative approximate linkage developed for this study. We manually reviewed matches identified by each method. RESULTS We identified 30,381 laboratory results showing rifampicin and fluoroquinolone susceptibility. Estimates of resistance development were 4% using methods A and B, and 8% using methods C and D. Across methods, 688 unique patients who developed fluoroquinolone resistance were identified, 598 of which were correct by manual review. Method D identified 587 (98%) of these correctly matched patients, the largest proportion across these methods. CONCLUSION Customised approximate linkage approaches maximised correct patient matches.

Schlagwörter

Stichwörter der Autor:innen

fluoroquinolone resistancelinking patient resultsrifampicin-resistant TBtuberculosis

Autor:innen und Institutionen

  • Division of Epidemiology, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Vanderbilt Tuberculosis Center, Nashville, TN, USA.
  • Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, and SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch Univ…
  • National Health Laboratory Service, Greenpoint Tuberculosis Laboratory, Cape Town, South Africa.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Rhea, C. H., Maruri, F., Ghebrekristos, Y., Amorim, G., Cox, H., Dheda, K., Sterling, T. R., Warren, R., & van der Heijden, Y. F. (2026). Quantifying emergent drug-resistant TB using laboratory data and record-linkage methods. IJTLD Open, 3(7), 428-434. https://doi.org/10.5588/ijtldopen.26.0043

Vancouver

Rhea CH, Maruri F, Ghebrekristos Y, Amorim G, Cox H, Dheda K, et al. Quantifying emergent drug-resistant TB using laboratory data and record-linkage methods. IJTLD Open. 2026;3(7):428-434. doi:10.5588/ijtldopen.26.0043

BibTeX
@article{Rhea2026,
  author = {Rhea, C H and Maruri, F and Ghebrekristos, Y and Amorim, G and Cox, H and Dheda, K and Sterling, T R and Warren, R and van der Heijden, Y F},
  title = {Quantifying emergent drug-resistant TB using laboratory data and record-linkage methods},
  journal = {IJTLD Open},
  year = {2026},
  volume = {3},
  number = {7},
  pages = {428--434},
  doi = {10.5588/ijtldopen.26.0043}
}
Kostenlos starten →